M Pharmaceutical’s eMosquito Could “provide convenience and comfort for those living with diabetes.”

M Pharmaceutical Inc. (CSE:MQ) recently sponsored an article on The Globe and Mail, which talked about the eMosquito aiming to “provide convenience and comfort for those living with diabetes.” According to Director, Dr. Martin Mintchev, “The eMosquito is a device that will automatically monitor their blood sugar levels throughout the day with less discomfort and stress than traditional methods. In addition, blood sugar data can be sent wirelessly to users’ smartphones and/or physicians, eliminating the need to carry bulky testing hardware.”

Click here for the article.

>Disclaimer: This content was sponsored by M Pharmaceutical Inc. (CSE:MQ)